SK Chemical announced that they won a suit of banning infringement of the patent against Novartis
On May 15, SK Chemical announced that they won a suit of banning infringement of the patent against Novartis.
The lawsuit is about 'Rivastigmine' which has efficacy in treatment of dementia, and
'Exelon patch' which put this material in a patch form. SK chemical was developing 'SID710 patch' wh...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
